Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Shiragami

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 6, 2006
Cost-effectiveness of including salmeterol in asthma therapy in a primary care setting in JapanTakehiko Miyagawa, Ichiro Arakawa, Makoto Shiragami, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 9, 2006
The realities and medical expense of hospitalization that originates in outpatient medicine treatmentMasayoshi Koinuma, Takahisa Yamanashi, Miwako Kamei, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 2, 2008
Pharmacoeconomic analysis of hypertriglyceridemia treatment at medical institutionsTsutomu Takahashi, Yoshiyasu Saegusa, Yukie Takimoto, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 2, 2009
[Patient needs for consultation with pharmacists]Fumihiro Someya, Hiroki Takuma, Megumi Izumisawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 8, 2010
[Cost-effectiveness of salmeterol/fluticasone combination therapy vs. fluticasone propionate in Japanese asthmatic patients]Yuji Tohda, Sankei Nishima, Ichiro Arakawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 24, 2003
[Calculation of drug information necessity factor of generic drugs]Hisashi Iijima, Teruyo Kurosaki, Miwako Kamei, et al.
Arerugi = [Allergy]|August 3, 2006
[Cost-effectiveness of fluticasone propionate for asthma episodes in Japanese patients with asthma--Fluticasone Investigation of Asthma Episode (FINE) study]Terumasa Miyamoto, Yutaka Morita, Gen Tamura, et al.
Infectious Diseases and Therapy|December 21, 2014
Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese ChildrenMakoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp, et al.
Dermatology and Therapy|April 23, 2018
The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model AnalysisDaisuke Watanabe, Akiko Mizukami, Katsiaryna Holl, et al.
Dermatology and Therapy|April 1, 2019
Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and OlderMakoto Shiragami, Akiko Mizukami, Toshihiko Kaise, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 6, 2006
Cost-effectiveness of including salmeterol in asthma therapy in a primary care setting in JapanTakehiko Miyagawa, Ichiro Arakawa, Makoto Shiragami, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 9, 2006
The realities and medical expense of hospitalization that originates in outpatient medicine treatmentMasayoshi Koinuma, Takahisa Yamanashi, Miwako Kamei, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 2, 2008
Pharmacoeconomic analysis of hypertriglyceridemia treatment at medical institutionsTsutomu Takahashi, Yoshiyasu Saegusa, Yukie Takimoto, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 2, 2009
[Patient needs for consultation with pharmacists]Fumihiro Someya, Hiroki Takuma, Megumi Izumisawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 8, 2010
[Cost-effectiveness of salmeterol/fluticasone combination therapy vs. fluticasone propionate in Japanese asthmatic patients]Yuji Tohda, Sankei Nishima, Ichiro Arakawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 24, 2003
[Calculation of drug information necessity factor of generic drugs]Hisashi Iijima, Teruyo Kurosaki, Miwako Kamei, et al.
Arerugi = [Allergy]|August 3, 2006
[Cost-effectiveness of fluticasone propionate for asthma episodes in Japanese patients with asthma--Fluticasone Investigation of Asthma Episode (FINE) study]Terumasa Miyamoto, Yutaka Morita, Gen Tamura, et al.
Infectious Diseases and Therapy|December 21, 2014
Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese ChildrenMakoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp, et al.
Dermatology and Therapy|April 23, 2018
The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model AnalysisDaisuke Watanabe, Akiko Mizukami, Katsiaryna Holl, et al.
Dermatology and Therapy|April 1, 2019
Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and OlderMakoto Shiragami, Akiko Mizukami, Toshihiko Kaise, et al.
Pageof 3